Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer
Erika Z Chung, David Alberico, Lakshmanan Sannachi, Archya Dasgupta, Joyce Yip, Maria Lourdes Anzola Pena, Sonal Gandhi, Belinda Curpen · 2026
Read Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer by Erika Z Chung, David Alberico, Lakshmanan Sannachi, Archya Dasgupta, Joyce Yip, Maria Lourdes Anzola Pena, Sonal Gandhi, Belinda Curpen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0346704.txt.
Description
Erika Z Chung, Belinda Curpen, and co-authors asked whether ultrasound measurements taken during the first weeks of chemotherapy can forecast how a breast tumor will finally respond. Chemotherapy before surgery is standard for several breast cancer types, but success is only confirmed afterward, too late to spare non-responders needless toxicity. Their 2026 study followed one hundred six patients with ultrasound at six points across treatment.
Patients whose tumors vanished completely showed steep shrinkage in width, area, and volume within the early weeks. Partial responders shrank steadily but less, weak responders barely moved, and non-responders stayed flat throughout. Statistical tests confirmed the early gap between complete responders and the rest. The authors conclude early size change carries real, if imperfect, predictive value for final response.
Catalog record
| CREATOR | Erika Z Chung, David Alberico, Lakshmanan Sannachi, Archya Dasgupta, Joyce Yip, Maria Lourdes Anzola Pena, Sonal Gandhi, Belinda Curpen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29238 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |